ArticleScientific reports2026
Association of serum TNF-α, IL-17 A, and IL-17 F levels with disease activity in Yemeni patients with rheumatoid arthritis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) is a persistent autoimmune disease stimulated by a sophisticated system of proinflammatory cytokines such as TNF-α and IL -17. They contribute significantly to the maintenance of inflammation and mediation of joint damage. The current study aimed to examine the relationship between serum concentrations of TNF-α, IL-17 A, and IL-17 F and disease activity in Yemeni RA patients. A case-control study was carried out on 101 RA patients and 80 healthy controls (HCs) matched for age and sex. The serum concentration of TNF-α, IL-17 A, and IL-17 F was determined through an enzyme-linked immunosorbent assay (ELISA). Other hematological, inflammatory parameters and serological tests were also assessed. TNF-α, IL-17 A and IL-17 F serum levels were significantly elevated in RA patients than in HCs (P < 0.001) and had a positive correlation with disease activity in RA groups (P < 0.001). Furthermore, a significant positive correlation between levels of TNF-α, IL-17 A, and IL-17 F and the DAS28. The ROC analysis revealed that all the three cytokines TNF-α, IL-17 A, and IL-17 F were effective in distinguishing between RA patients and HCs, with TNF-α having the highest diagnostic accuracy. To define moderate to high disease activity, IL-17 A demonstrated the best individual quality, whereas TNF-α and IL-17 F demonstrated moderate quality. Interaction of the cytokines improved the diagnostic value as both TNF-α and IL-17 A combination and triple combination of TNF-α, IL-17 A and IL17F which supports the benefits of multiplex cytokine testing in RA activity testing as well as discrimination of moderate to high activity RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.